CDH Giant Health I Limited

CDH Giant Health I Limited is a Chinese private equity firm focusing on large growth, restructuring, and buyout investments. The firm is dedicated to creating long-term tangible value for its portfolio companies by allocating extensive resources to help them transform industry patterns and generate social value. CDH Giant Health I Limited aims to drive its portfolio companies to accelerate China's industrial transformation and improve the quality of people's lives. Over the past 20 years, the firm has invested in more than 100 outstanding companies in sectors such as Consumer & Services, Healthcare, and Advanced Manufacturing. The firm has successfully navigated multiple economic cycles and optimized its investment strategy to follow the economic cycle, transitioning from minority to control investments. CDH Giant Health I Limited maintains long-standing trusted relationships and partnerships with its portfolio companies, continuously delivering significant value-added services to entrepreneurs and accompanying them on their journey to excellence. The firm supports companies in completing organizational transformations at critical moments to generate multiplier effects. As companies grow, CDH Giant Health I Limited provides robust industrial resource integration capabilities, in-depth global insights, and professional guidance to boost their second growth curve. With specialized capabilities to efficiently handle innovative and complex transactions, the firm helps Chinese companies position themselves as leaders in the global market. CDH Giant Health I Limited has practiced outbound investment with its portfolios and has conducted more than 10 M&A transactions with a cumulative transaction value exceeding US$18.5 billion over the past few years. The firm works with entrepreneurs to think beyond and dream bigger by helping them cross the threshold of growth through M&A and providing a strong impetus for development.

CDH Giant Health I Limited's investment focus spans various industries, including healthcare, consumer & services, advanced manufacturing, information technology, media, telecommunication technology, industrial manufacturing, education, finance, energy, clean technology, medical, retail, consumer products, and the agricultural industry. The firm's diversified portfolio reflects its commitment to supporting companies across multiple sectors and regions. CDH Giant Health I Limited's strategic approach emphasizes sustainable value creation and long-term growth for its portfolio companies, positioning them for success in the global market.

With a strong track record of successful investments and a commitment to excellence, CDH Giant Health I Limited continues to be a significant player in the private equity landscape, driving innovation and growth across its diverse portfolio. The firm's focus on healthcare and advanced manufacturing sectors aligns with China's economic development goals, contributing to the transformation and modernization of these industries. CDH Giant Health I Limited's expertise in managing complex transactions and its global insights enable it to identify and capitalize on investment opportunities that offer substantial returns and strategic value for its stakeholders.